In addition, Zhou et al. showed a higher expression of HOTAIR and a lower PTEN expression in samples of patients with relapsed and refractory AML and doxorubicin-resistant cell lines compared to control samples. The gene discussed is HOTAIR; the disease is acute myeloid leukemia.